Buy analyst ratings: USA
12,325 dated buy ratings on 1,209 USA stocks (listed in the US), newest first. The firms' own words in this tab: Buy, Outperform, Overweight. Each row is as the research firm published it in its public rating disclosure. Not investment advice and not a consensus.
- 2025-08-04: Stock CRBG; Price Target $47.00; Price When Rated $34.79; Upside / Downside +35.10%.
- 2025-08-04: Stock EHC; Price Target $141.00; Price When Rated $109.50; Upside / Downside +28.77%.
- 2025-08-04: Stock EME; Price Target $750.00; Price When Rated $629.22; Upside / Downside +19.20%.
- 2025-08-04: Stock FHN; Price Target $26.00; Price When Rated $21.67; Upside / Downside +19.98%.
| Date | Stock | Price Target | Price When Rated | Upside / Downside | Analyst | Firm | Rating |
|---|---|---|---|---|---|---|---|
| 2025-08-04 | CRBG Corebridge Financial, Inc. | $47.00 | $34.79 | +35.10% | Alex Scott | Barclays | Overweight |
| 2025-08-04 | EHC Encompass Health Corp | $141.00 | $109.50 | +28.77% | Andrew Mok | Barclays | Overweight |
| 2025-08-04 | EME EMCOR Group, Inc. | $750.00 | $629.22 | +19.20% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | FHN FIRST HORIZON CORP | $26.00 | $21.67 | +19.98% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | HIG HARTFORD INSURANCE GROUP, INC. | $150.00 | $126.21 | +18.85% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | INSP Inspire Medical Systems, Inc. | $230.00 | $129.95 | +76.99% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | NI NISOURCE INC. | $44.00 | $42.59 | +3.31% | Nicholas Campanella | Barclays | Overweight |
| 2025-08-04 | OSK OSHKOSH CORP | $164.00 | $136.84 | +19.85% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | PRIM Primoris Services Corp | $110.00 | $93.09 | +18.17% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | PUMP ProPetro Holding Corp. | $6.00 | $5.07 | +18.34% | Eddie Kim J. David Anderson | Barclays | Overweight |
| 2025-08-04 | RYAN RYAN SPECIALTY HOLDINGS, INC. | $80.00 | $57.82 | +38.36% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | SSB SouthState Bank Corp | $122.00 | $93.59 | +30.36% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | TT Trane Technologies plc | $544.00 | $433.97 | +25.35% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | VNT Vontier Corp | $50.00 | $41.21 | +21.33% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | W Wayfair Inc. | $91.00 | $73.48 | +23.84% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | WTFC WINTRUST FINANCIAL CORP | $160.00 | $124.85 | +28.15% | Not named | UBS Investment Bank | Buy |
| 2025-08-04 | XYL Xylem Inc. | $168.00 | $143.97 | +16.69% | Not named | UBS Investment Bank | Buy |
| 2025-08-03 | BRK.A BERKSHIRE HATHAWAY INC | $895,247.00 | $711,480.00 | +25.83% | Not named | UBS Investment Bank | Buy |
| 2025-08-03 | BRK.B BERKSHIRE HATHAWAY INC | $895,247.00 | $711,480.00 | +25.83% | Not named | UBS Investment Bank | Buy |
| 2025-08-03 | CVX CHEVRON CORP | $186.00 | $151.40 | +22.85% | Not named | UBS Investment Bank | Buy |
| 2025-08-03 | DINO HF Sinclair Corp | $51.00 | $42.36 | +20.40% | Not named | UBS Investment Bank | Buy |
| 2025-08-03 | KGC KINROSS GOLD CORP | $20.00 | $16.21 | +23.38% | Not named | UBS Investment Bank | Buy |
| 2025-08-03 | PBF PBF Energy Inc. | $28.00 | $21.68 | +29.15% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | ACN Accenture plc | $363.00 | $255.37 | +42.15% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | AEE AMEREN CORP | $118.00 | $102.11 | +15.56% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $550.00 | $401.80 | +36.88% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | AVTR Avantor, Inc. | $13.00 | $13.44 | -3.27% | Luke Sergott | Barclays | Overweight |
| 2025-08-01 | BIO BIO-RAD LABORATORIES, INC. | $325.00 | $284.60 | +14.20% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | BIO.B BIO-RAD LABORATORIES, INC. | $325.00 | $284.60 | +14.20% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | CGNX COGNEX CORP | $58.00 | $40.47 | +43.32% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | COF CAPITAL ONE FINANCIAL CORP | $270.00 | $207.47 | +30.14% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | EIX EDISON INTERNATIONAL | $65.00 | $52.12 | +24.71% | Nicholas Campanella | Barclays | Overweight |
| 2025-08-01 | EVRG Evergy, Inc. | $81.00 | $71.55 | +13.21% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | FBIN Fortune Brands Innovations, Inc. | $83.00 | $55.83 | +48.67% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | GFL GFL Environmental Inc. | $63.00 | $49.78 | +26.56% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | GIL Gildan Activewear Inc. | $75.00 | $51.17 | +46.57% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | ICE Intercontinental Exchange, Inc. | $212.00 | $185.74 | +14.14% | Benjamin Budish | Barclays | Overweight |
| 2025-08-01 | ICE Intercontinental Exchange, Inc. | $215.00 | $184.60 | +16.47% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | IMO IMPERIAL OIL LTD | $129.00 | $114.90 | +12.27% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | JPM JPMORGAN CHASE & CO | $339.00 | $289.37 | +17.15% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | KKR KKR & Co. Inc. | $165.00 | $146.58 | +12.57% | Benjamin Budish | Barclays | Overweight |
| 2025-08-01 | NBIX NEUROCRINE BIOSCIENCES INC | $188.00 | $128.91 | +45.84% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | PNC PNC FINANCIAL SERVICES GROUP, INC. | $224.00 | $185.88 | +20.51% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | RMD RESMED INC | $325.00 | $279.20 | +16.40% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | SPXC SPX Technologies, Inc. | $210.00 | $196.36 | +6.95% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | TFC TRUIST FINANCIAL CORP | $53.00 | $42.96 | +23.37% | Not named | UBS Investment Bank | Buy |
| 2025-08-01 | VMC Vulcan Materials CO | $305.00 | $274.67 | +11.04% | Adam Seiden | Barclays | Overweight |
| 2025-08-01 | WHD Cactus, Inc. | $52.00 | $42.31 | +22.90% | J. David Anderson | Barclays | Overweight |